The Cutaneous Lymphoma Foundation offers two Young Investigator Awards each year to new physicians and scientists in the field of cutaneous lymphoma research.
Since 2003, this annual award has been given to support travel to the Society for Investigative Dermatology (SID) Annual Meeting and participation in the concurrent CTCL Symposium. Due to the positive response of the initial award in 2011, we began offering a second award to an investigator presenting at the American Society of Hematology (ASH) Annual Meeting.
Criteria for selection of the Young Investigator Award includes:
- Individuals with a MD or PhD degree.
- Individuals with an academic rank no greater than assistant professor.
- Individuals with demonstrable interest and/or achievement in clinical care, education or research in cutaneous lymphomas.
- Individuals who have submitted an abstract and will presenting research at the either the ASH or SID annual meeting.
About Our 2017 American Society of Hematology Young Investigator Award Recipient
The Cutaneous Lymphoma Foundation is pleased to announce Bethany Mundy-Bosse, PhD, as the recipient of the 2017 Young Investigator Award for travel to present her research at the American Society of Hematology (ASH) annual meeting. Dr. Mundy-Bosse is a Research Assistant Professor in the Division of Hematology at Ohio State University in Columbus, Ohio. Her awarded research proposes a relationship between the increased expression of interleukin (IL)-15 in malignant CD4+ T cells in CTCL patients and NK cells. Her findings suggest further investigations aimed at understanding the disconnect between NK cell numbers, activation, and disease control in CTCL patients are warranted.
About our 2017 Society of Investigative Dermatology Young Investigator Award Recipient
The Cutaneous Lymphoma Foundation is pleased to announce Adèle de Masson, MD, as the recipient of its 2017 Young Investigator Award (YIA) travel grant to the Society for Investigative Dermatology (SID) Annual Meeting. Dr. de Masson's research focus is identifying a method to predict which individuals are likely to progress to more advanced stages of cutaneous lymphoma.